Somatostatin Receptor
Somatostatin receptor is a G protein-coupled receptor that includes five known somatostatin receptors.
Products Related to Somatostatin Receptor(43)
- GC62381BIM-23190 hydrochloridePurity: >98.50%
BIM-23190 hydrochloride, a somatostatin analog, a selective SSRT2 and SSRT5 agonist, exhibits Ki values of 0.34 nM and 11.1 nM for SSTR2 and SSTR5, respectively. BIM-23190 can be used in the study for cancer and acromegaly.
- GC62843Angiopeptin TFACAS: 2478421-60-0Purity: >99.00%
Angiopeptin TFA, a cyclic octapeptide analogue of somatostatin, is a weak sst2/sst5 receptor partial agonist with IC50 values of 0.26?nM and 6.92?nM, respectively.
- GC63137PaltusotineCAS: 2172870-89-0Purity: >98.50%
Paltusotine (CRN00808) is an orally active, nonpeptide selective somatostatin type 2 (SST2) receptor agonist.
- GC64259SSTR5 antagonist 2 hydrochlorideCAS: 2988224-31-1Purity: >99.00%
SSTR5 antagonist 2 hydrochloride is a highly potent, oral active and selective somatostatin (receptor) subtype 5 (SSTR5) antagonist and has potential for the research of type 2 diabetes mellitus (T2DM).
- GC65313SSTR5 antagonist 1CAS: 1628741-91-2Purity: >99.00%
SSTR5 antagonist 1 is a potent, selective, and orally available somatostatin receptor subtype 5 (SSTR5) antagonist with IC50s of 9.6 and 57 nM for hSSTR5 and mSSTR5, respectively.
- GC69003DOTA-LM3 TFAPurity: >99.00%
DOTA-LM3 TFA is a growth hormone receptor (SSTR) antagonist. LM3 refers to p-Cl-Phe-cyclo(D-Cys-Tyr-D-4-amino-Phe(carbamoyl)-Lys-Thr-Cys)D-Tyr-NH2, which is also a somatostatin antagonist. DOTA-LM3 TFA is commonly used as an isotopic label for in vivo tumor tracking, such as 177Lu-DOTA-LM3 TFA and 68 Ga-DOTA-LM3 TFA. 68 Ga-DOTA-LM3 TFA has good biological distribution, high tumor uptake, good tumor retention and fewer safety issues. 177Lu-DOTA-LM3 TFA can be used for the study of DOTATOC-negative liver metastases, such as pancreatic NETs and extensive tumor thrombosis.
- GC72086Veldoreotide TFACAS: 2126831-23-8Purity: >98.00%
Veldoreotide (DG3173) TFA a somatostatin analogue, binds to and activate the somatostatin receptors (SSTR) 2, 4, and 5.
- GC74368[Nle8] Somatostatin (1-28) (TFA)Purity: >99.00%
[Nle8] Somatostatin (1-28) TFA is a derivative of somatosttin (1-28) with norleucine replacing methionine in position 8.
- GC79316L-797591 hydrochlorideCAS: 3026641-74-4Purity: >99.50%
L-797591 hydrochloride is a selective sst 1 agonist.
- GC79317SSTR3 Agonist-1CAS: 3086695-73-7Purity: >98.00%
SSTR3 Agonist-1 (Compound EX 38) is an orally active SSTR3 agonist, with an EC 50 of 0.14 nM.
- GC79504(R)-VerapamilCAS: 38321-02-7Purity: >98.50%
(R)-Verapamil (Dexverapamil) is an optically enantiomer of the oral-active Verapamil.
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC62381 | BIM-23190 hydrochloride | - | >98.50% | |
BIM-23190 hydrochloride, a somatostatin analog, a selective SSRT2 and SSRT5 agonist, exhibits Ki values of 0.34 nM and 11.1 nM for SSTR2 and SSTR5, respectively. BIM-23190 can be used in the study for cancer and acromegaly. | ||||
| GC62843 | Angiopeptin TFA | 2478421-60-0 | >99.00% | |
Angiopeptin TFA, a cyclic octapeptide analogue of somatostatin, is a weak sst2/sst5 receptor partial agonist with IC50 values of 0.26?nM and 6.92?nM, respectively. | ||||
| GC63137 | Paltusotine | 2172870-89-0 | >98.50% | |
Paltusotine (CRN00808) is an orally active, nonpeptide selective somatostatin type 2 (SST2) receptor agonist. | ||||
| GC64259 | SSTR5 antagonist 2 hydrochloride | 2988224-31-1 | >99.00% | |
SSTR5 antagonist 2 hydrochloride is a highly potent, oral active and selective somatostatin (receptor) subtype 5 (SSTR5) antagonist and has potential for the research of type 2 diabetes mellitus (T2DM). | ||||
| GC64635 | AGI-43192 | 2377491-54-6 | >99.00% | |
AGI-43192 is a potent inhibitor of methionine adenosyltransferase 2A (MAT2A). | ||||
| GC64665 | AGI-41998 | 2377492-26-5 | >99.00% | |
AGI-41998 is a potent inhibitor of methionine adenosyltransferase 2A (MAT2A). | ||||
| GC65313 | SSTR5 antagonist 1 | 1628741-91-2 | >99.00% | |
SSTR5 antagonist 1 is a potent, selective, and orally available somatostatin receptor subtype 5 (SSTR5) antagonist with IC50s of 9.6 and 57 nM for hSSTR5 and mSSTR5, respectively. | ||||
| GC69003 | DOTA-LM3 TFA | - | >99.00% | |
DOTA-LM3 TFA is a growth hormone receptor (SSTR) antagonist. LM3 refers to p-Cl-Phe-cyclo(D-Cys-Tyr-D-4-amino-Phe(carbamoyl)-Lys-Thr-Cys)D-Tyr-NH2, which is also a somatostatin antagonist. DOTA-LM3 TFA is commonly used as an isotopic label for in vivo tumor tracking, such as 177Lu-DOTA-LM3 TFA and 68 Ga-DOTA-LM3 TFA. 68 Ga-DOTA-LM3 TFA has good biological distribution, high tumor uptake, good tumor retention and fewer safety issues. 177Lu-DOTA-LM3 TFA can be used for the study of DOTATOC-negative liver metastases, such as pancreatic NETs and extensive tumor thrombosis. | ||||
| GC72086 | Veldoreotide TFA | 2126831-23-8 | >98.00% | |
Veldoreotide (DG3173) TFA a somatostatin analogue, binds to and activate the somatostatin receptors (SSTR) 2, 4, and 5. | ||||
| GC72197 | Cortistatin 29 | - | >99.00% | |
Cortistatin 29 is a neuropeptide. | ||||
| GC74368 | [Nle8] Somatostatin (1-28) (TFA) | - | >99.00% | |
[Nle8] Somatostatin (1-28) TFA is a derivative of somatosttin (1-28) with norleucine replacing methionine in position 8. | ||||
| GC74393 | DOTA-LM3 | 1192362-32-5 | >98.00% | |
DOTA-LM3 is a somatostatin receptor (SSTR) antagonist. | ||||
| GC74394 | DOTA-JR11 | 1039726-31-2 | >98.00% | |
DOTA-JR11 is a somatostatin receptor 2 (SSTR2)antagonist. | ||||
| GC74405 | NODAGA-LM3 | - | >99.00% | |
NODAGA-LM3 can be labeled by 68Ga for PET imaging. | ||||
| GC79316 | L-797591 hydrochloride | 3026641-74-4 | >99.50% | |
L-797591 hydrochloride is a selective sst 1 agonist. | ||||
| GC79317 | SSTR3 Agonist-1 | 3086695-73-7 | >98.00% | |
SSTR3 Agonist-1 (Compound EX 38) is an orally active SSTR3 agonist, with an EC 50 of 0.14 nM. | ||||
| GC79318 | NOTA-TATE | 709043-21-0 | >98.50% | |
NOTA-TATE is a somatostatin receptor 2 ( SSTR2 ) binder. | ||||
| GC79504 | (R)-Verapamil | 38321-02-7 | >98.50% | |
(R)-Verapamil (Dexverapamil) is an optically enantiomer of the oral-active Verapamil. | ||||
| GC10729 | Pasireotide | 396091-73-9 | >98% | |
stable cyclohexapeptide somatostatin mimic | ||||
